Leah Brackensick

Leah Brackensick

Locke Lord LLP

Contact
View Bio
RSS

Latest Posts › Orphan Drugs

Share:

Ensuring Innovation Act Alters Eligibility for New Chemical Exclusivity

On April 23, 2021, President Biden signed into law The Ensuring Innovation Act (S. 415), which amends the requirements for New Chemical Entity (NCE) and Orphan Drug (ODE) exclusivities under the Federal Food, Drug, and...more

4/27/2021  /  Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Innovation , Orphan Drugs , Pharmaceutical Industry
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide